Thus, this systematic review proposes that the co-inhibition of PD-L1 expression and EMT status through the TGF-β and PI3K-AKT pathways may provide new insights into the inhibition of tumor invasion and metastatic progression in these malignancies. This evidence concerns the gene CD274 and neoplasm.